Delivery Order SPE2DB22D3009-SPE2DB25FBD86
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Procainamide 1 gram/10 mL vials. This competitive, non-set-aside award carries a ceiling value of $3,145.00 and is scheduled for completion by August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,505.03. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $1,704.20 and an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Procainamide is an...
- The Defense Logistics Agency awarded a delivery order valued at $4,352.76 to AmerisourceBergen Drug Corp for the supply of Procainamide 1,000 mg/2 mL vials. This contract, which was competitively awarded without set-aside provisions, carries a firm fixed price and an ultimate completion date of August 4, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 vehicle...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Procainamide 1 gram/10 mL vials totaling $1,484.44. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance to take place at the vendor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a contract ceiling value of $4,296.26. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award represents...
- On August 1, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,774.03 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed price contract represents a non-competitive award and is scheduled for completion by August 4, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order operates as a child contract...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,051.71 delivery order to AmerisourceBergen Drug Corp for Procainamide 1 gram/10 mL vials on July 29, 2025, with completion targeted for July 30, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBD86Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,129.80 for the supply of Procainamide 1,000 mg/10 ml vials on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's Medical Supply Chain operations, enabling the distribution of pharmaceutical products to military and veteran healthcare systems. Procainamide is a cardiac antiarrhythmic medication critical for military medical readiness. AmerisourceBergen's comprehensive IDC vehicle facilitates the supply of a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 8/22/25 |